CTSO

Cytosorbents Corp

4.80

Nov 06 • 3:59 PM ET +0.20 (4.35%)

4.80

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Nano NASD

Peers: AEMD NUWE CERS OM BJDX HAE NEPH RMTI DXR BAX

| Held by: VTI VXF MSSM

Scroll to Statements

Index	-
Market Cap	15.13M
Enterprise Value	40.70M
Income	-18.21M
Sales	37.22M
Book/sh	-0.24
Cash/sh	1.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	129
IPO	Aug 08, 2006

P/E	-
Forward P/E	-
PEG	-
P/S	0.41
P/B	-
P/C	3.43
P/FCF	-
EV/EBITDA	-
EV/Sales	1.09
Quick Ratio	0.50
Current Ratio	0.66
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-5.80
EPS next Y	-0.68
EPS next Q	-0.90
EPS this Y	-72.18%
EPS next Y	84.74%
EPS next 5Y	-
EPS past 3/5Y	44.07% 8.18%
Sales past 3/5Y	2.23% -2.00%
EPS Y/Y TTM	-61.01%
Sales Y/Y TTM	8.64%
EPS Q/Q	-342.60%
Sales Q/Q	0.17%
Earnings	Nov 12 AMC
EPS/Sales Surpr.	-55.56% 2.64%

Insider Own	13.98%
Insider Trans	129.31%
Inst Own	24.48%
Inst Trans	-1.03%
ROA	-42.38%
ROE	-336.19%
ROIC	-130.68%
Gross Margin	71.61%
Oper. Margin	-31.60%
Profit Margin	-48.94%
SMA20	6.27%
SMA50	-4.58%
SMA200	-48.17%
Trades

Shs Outstand	3.14M
Shs Float	2.71M
Short Float	4.22%
Short Ratio	3.35
Short Interest	0.11M
52W High	17.00 -71.76%
52W Low	2.84 69.00%
Volatility	18.47% 18.09%
ATR (14)	0.71
RSI (14)	51.28
Beta	1.45
Rel Volume	0.41
Avg Volume	34.14K
Volume	13,987

Perf Week	5.73%
Perf Month	28.69%
Perf Quarter	-33.70%
Perf Half Y	-60.59%
Perf YTD	-62.45%
Perf Year	-66.22%
Perf 3Y	-82.09%
Perf 5Y	-96.17%
Perf 10Y	-95.56%
Recom	2.50
Target Price	34.83
Prev Close	4.60
Price	4.80
Change %	4.35%

Consensus

Buy

Avg. Price Target

$34.83

Implied Upside

+625.6%

Analysts8incl. previous ratings

Rating Distribution8 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 07, 2023	Initiated	RB. Riley Securities	Buy	$4	-16.7%
Oct 14, 2021	Resumed	RB. Riley Securities	Buy	$10	+108.3%
Sep 17, 2020	Initiated	JJefferies	Buy	$15	+212.5%
Sep 01, 2020	Initiated	SSVB Leerink	Outperform	$15	+212.5%
Aug 08, 2017	Reiterated	MMaxim Group	Buy	$10 → $12	+150.0%
Oct 26, 2016	Initiated	AAegis Capital	Buy
May 24, 2016	Initiated	MMaxim Group	Buy	$8	+66.7%
Oct 29, 2015	Upgrade	WWBB Securities	Speculative Buy → Buy	$13 → $13	+170.8%
May 12, 2015	Reiterated	MMLV & Co	Buy	$28 → $21	+337.5%
Apr 01, 2015	Reiterated	MMLV & Co	Buy	$28 → $30	+525.0%
Mar 05, 2015	Initiated	MMLV & Co	Buy	$30	+525.0%
Feb 25, 2015	Initiated	WWBB Securities	Speculative Buy	$13	+170.8%
Jan 27, 2015	Reiterated	HH.C. Wainwright	Buy	$1 → $12	+150.0%

Nov-06-26 05:58PM	CytoSorbents Must Prove Its Cash Breakeven Promise As The DrugSorb Clock Keeps Ticking (Earnings Whispers)
Oct-29-26 07:00AM	CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights (PR Newswire) -16.03%
Sep-30-26 07:00AM	CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care (PR Newswire)
Sep-23-26 07:00AM	CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -7.71%
Sep-10-26 07:00AM	CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference (PR Newswire)
09:09AM	Loading…
Sep-04-26 09:09AM	CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference (Newsfile)
Sep-03-26 07:00AM	CytoSorbents Announces Reverse Stock Split (PR Newswire) -8.81%
Sep-02-26 07:28AM	CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings (PR Newswire) +13.55%
Aug-07-26 01:08AM	CytoSorbents Corp (CTSO) (Q2 2026) Earnings Call Highlights: Nearing Breakeven with Strong ... (GuruFocus.com) -9.68%
Aug-06-26 05:09PM	CytoSorbents: Q2 Earnings Snapshot (Associated Press)
04:25PM	CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update (PR Newswire)
Jul-20-26 07:00AM	CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights (PR Newswire) +5.58%
May-14-26 01:02AM	CytoSorbents Corp (CTSO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com) -5.05%
May-13-26 04:03PM	CytoSorbents: Q1 Earnings Snapshot (Associated Press)
04:00PM	CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update (PR Newswire)
07:00AM	Loading…
Apr-30-26 07:00AM	CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights (PR Newswire)
Mar-25-26 11:01PM	CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... (GuruFocus.com) -10.61%
04:33PM	CytoSorbents: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights (PR Newswire)
Mar-19-26 09:44AM	CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 (PR Newswire)
Mar-05-26 07:00AM	CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights (PR Newswire)
Jan-12-26 07:00AM	CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update (PR Newswire)
Dec-10-25 07:00AM	CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 (PR Newswire) -12.34%
Nov-17-25 05:42PM	Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London (PR Newswire) -5.29%
Nov-14-25 12:03AM	CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Nov-13-25 04:58PM	CytoSorbents: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
Nov-11-25 07:00AM	CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London (PR Newswire)
Oct-30-25 07:00AM	CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights (PR Newswire)
Oct-28-25 07:00AM	In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer (PR Newswire)
07:00AM	Loading…
Sep-29-25 07:00AM	CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen (PR Newswire)
Sep-16-25 07:00AM	CytoSorbents Provides DrugSorb-ATR Regulatory Update (PR Newswire)
Sep-08-25 07:00AM	CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day (PR Newswire)
Sep-05-25 07:00AM	CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference (PR Newswire)
Aug-20-25 07:00AM	CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR (PR Newswire) -17.23%
Aug-07-25 04:10PM	CytoSorbents: Q2 Earnings Snapshot (Associated Press Finance) +11.96%
04:00PM	CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
Jul-31-25 07:00AM	CytoSorbents Leads a New Era in Sepsis Treatment (PR Newswire) -7.61%
Jul-29-25 07:00AM	CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights (PR Newswire)
Jul-02-25 07:00AM	CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR (PR Newswire) -22.48%
Jun-24-25 07:00AM	CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR (PR Newswire)
May-29-25 07:00AM	CytoSorbents to Participate at the Jefferies Global Healthcare Conference (PR Newswire)
May-22-25 09:27AM	CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025 (PR Newswire)
May-15-25 08:58AM	Q1 2025 Cytosorbents Corp Earnings Call (Thomson Reuters StreetEvents)
03:16AM	CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
May-14-25 04:50PM	CytoSorbents: Q1 Earnings Snapshot (Associated Press Finance) -7.11%
04:01PM	CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
May-13-25 09:47AM	CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-01-25 04:15PM	CytoSorbents Provides Regulatory Update for DrugSorb-ATR (PR Newswire) -6.93%
Apr-29-25 07:00AM	CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights (PR Newswire)
Apr-21-25 07:00AM	CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program (PR Newswire) +5.83%
Apr-17-25 07:00AM	CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller (PR Newswire)
Apr-14-25 07:00AM	CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America (PR Newswire)
Apr-04-25 07:00AM	CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants (PR Newswire)
Apr-01-25 06:44AM	Q4 2024 Cytosorbents Corp Earnings Call (Thomson Reuters StreetEvents)
03:04AM	CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-31-25 07:51PM	Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
04:59PM	CytoSorbents: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights (PR Newswire)
Mar-24-25 09:05AM	CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Mar-21-25 07:00AM	CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit (PR Newswire) -9.77%
Mar-05-25 07:32AM	CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com) +14.00%
Mar-04-25 07:00AM	CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller (GlobeNewswire)
Feb-26-25 07:00AM	CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
Feb-25-25 07:00AM	CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants (GlobeNewswire)
Jan-14-25 09:35AM	Cytosorbents Boosts Liquidity with Successful Rights Offering (TipRanks)
Jan-13-25 07:00AM	CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering (GlobeNewswire) +11.98%
Jan-06-25 07:00AM	CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai (GlobeNewswire) +11.04%
Jan-04-25 08:15AM	CytoSorbents reported strong Q4 results, says D. Boral Capital (TipRanks)
Jan-03-25 07:00AM	CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue (GlobeNewswire)
Dec-23-24 07:00AM	CytoSorbents Rights Offering Begins (GlobeNewswire) -8.37%
Dec-12-24 07:00AM	CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week (GlobeNewswire)
Dec-09-24 07:00AM	CytoSorbents Announces Rights Offering (GlobeNewswire)
Nov-26-24 07:00AM	CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-11-24 07:30AM	CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India (GlobeNewswire) +25.68%
Nov-08-24 04:03PM	CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ... (GuruFocus.com) -18.05%
Nov-07-24 05:58PM	CytoSorbents: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CytoSorbents Reports Third Quarter 2024 Financial and Operational Results (GlobeNewswire)
Nov-06-24 07:54AM	CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com) +6.61%
Nov-04-24 07:00AM	CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification (GlobeNewswire) -12.95%
Oct-22-24 07:00AM	FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review (GlobeNewswire)
Oct-17-24 07:00AM	CytoSorbents to Report Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-09-24 06:19PM	CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) -7.08%
Oct-01-24 07:00AM	CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update (GlobeNewswire) -10.00%
Aug-27-24 07:00AM	CytoSorbents to Present at the H.C. Wainwright 26?? Annual Global Investment Conference (GlobeNewswire)
Aug-16-24 04:05PM	CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-13-24 05:45PM	CytoSorbents: Q2 Earnings Snapshot (Associated Press Finance) +7.99%
04:19PM	CytoSorbents Reports Second Quarter 2024 Financial and Operational Results (GlobeNewswire)
04:18PM	CytoSorbents Appoints Peter J. Mariani Chief Financial Officer (GlobeNewswire)
Aug-07-24 07:00AM	CytoSorbents to Report Second Quarter 2024 Operating and Financial Results (GlobeNewswire) +7.92%
Aug-01-24 07:00AM	CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jul-30-24 02:00AM	CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website (GlobeNewswire)
Jul-29-24 08:00AM	CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website (GlobeNewswire) +17.48%
Jul-17-24 07:00AM	CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress (GlobeNewswire)
Jul-02-24 07:00AM	CytoSorbents Secures $20 Million Credit Facility (GlobeNewswire) +17.40%
Jun-24-24 07:00AM	CytoSorbents Announces Regulatory Approval of CytoSorb in Taiwan (GlobeNewswire)
Jun-13-24 07:00AM	CytoSorbents Announces the Launch and Immediate Availability of the PuriFi Blood Pump in the European Union (GlobeNewswire)
Jun-05-24 07:00AM	CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting (GlobeNewswire) +5.04%
Jun-04-24 07:00AM	CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chan Phillip P.	Chief Executive Officer	Sep 15 '26	Buy	6.00	3,774	22,644	100,996	Sep 16 05:30 PM
Capponi Vincent	President and COO	Sep 14 '26	Buy	6.05	2,073	12,537	40,387	Sep 16 04:05 PM
Sobel Alan D.	Director	Sep 15 '26	Buy	6.10	2,500	15,254	9,887	Sep 16 04:05 PM
Chan Phillip P.	Chief Executive Officer	Sep 04 '26	Buy	0.35	200,000	70,000	1,944,432	Sep 09 04:05 PM
MARIANI PETER J	Chief Financial Officer	Jun 15 '26	Buy	0.44	100,000	44,000	638,113	Jun 16 07:00 AM
Chan Phillip P.	Chief Executive Officer	Jun 12 '26	Buy	0.40	251,136	100,454	1,734,099	Jun 15 06:24 PM
Chan Phillip P.	Chief Executive Officer	Jun 15 '26	Buy	0.43	10,333	4,443	1,744,432	Jun 15 06:24 PM

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Ph.D.Dr. Phillip P. Chan M.D.

President & COOMr. Vincent J. Capponi M.S.

Chief Financial OfficerMr. Peter J. Mariani CPA

FESCDr. Efthymios N. Deliargyris FACC

Executive Vice President of Sales & MarketingDr. Christian Steiner M.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CTSO

Cytosorbents Corp

Upgrade your Finviz experience